MetaVia Inc. SEC filings MTVA
MetaVia Inc. has 633 filings in SEC EDGAR's recent list, going back to Apr 8, 2015. Its latest annual report, Form ARS, was filed on Apr 27, 2026 for the period ended Dec 31, 2025. The latest quarterly report (Form 10-Q) was filed on Aug 6, 2026, covering the quarter ended Jun 30, 2026. The most recent current report (Form 8-K) was filed on Nov 5, 2026 (regulation fd disclosure, other events). The company's fiscal year ends on December 31.
| Form | Description | Filed | Period |
|---|---|---|---|
| DEF 14A | Proxy statement | Apr 27, 2026 | Jun 8, 2026 |
| PRE 14A | Preliminary proxy statement | Apr 15, 2026 | Jun 8, 2026 |
| DEF 14A | Proxy statement | Jun 10, 2025 | Jun 30, 2025 |
| PRE 14A | Preliminary proxy statement | May 27, 2025 | Jun 30, 2025 |
| DEF 14A | Proxy statement | Aug 21, 2024 | Sep 18, 2024 |
| PRE 14A | Preliminary proxy statement | Aug 7, 2024 | Sep 18, 2024 |
| DEF 14A | Proxy statement | Apr 30, 2024 | Jun 7, 2024 |
| DEF 14A | Proxy statement | May 26, 2023 | Jun 28, 2023 |
| PRE 14A | Preliminary proxy statement | May 16, 2023 | Jun 28, 2023 |
| DEF 14A | Proxy statement | Nov 28, 2022 | Dec 22, 2022 |
| PRE 14A | Preliminary proxy statement | Nov 15, 2022 | Dec 22, 2022 |
| DEF 14A | Proxy statement | May 18, 2022 | Jun 9, 2022 |
| PRE 14A | Preliminary proxy statement | May 6, 2022 | Jun 9, 2022 |
| DEF 14A | Proxy statement | Jul 26, 2021 | Aug 18, 2021 |
| DEF 14A | Proxy statement | Jun 15, 2021 | Jul 9, 2021 |
| PRE 14A | Preliminary proxy statement | Feb 2, 2021 | Mar 12, 2021 |
| DEF 14A | Proxy statement | Apr 29, 2020 | Jun 18, 2020 |
| DEFA14A | Additional proxy material | May 3, 2018 | — |
| DEF 14A | Proxy statement | Apr 17, 2018 | May 22, 2018 |
| DEF 14A | Proxy statement | Apr 6, 2017 | May 23, 2017 |
Showing 20 filings. Main filings leave out insider and ownership forms such as Form 4; choose a type above to see them. Each form opens on SEC.gov. Older filings are on SEC EDGAR.
New to this? Read What Are SEC Filings? 10-K, 10-Q, 8-K and Other Forms Explained.
Company profile
- Industry
- Pharmaceutical Preparations (SIC 2834)
- Listed as
- MTVA (Nasdaq)
- Fiscal year ends
- December 31
- Incorporated in
- DE
- Headquarters
- Cambridge, MA
- SEC filer status
- Non-accelerated filer, Smaller reporting company
- SEC CIK
- 1638287
- Former names
- NeuroBo Pharmaceuticals, Inc. (until Nov 18, 2024); Gemphire Therapeutics Inc. (until Dec 31, 2019)
Other Pharmaceutical Preparations companies
- ELI LILLY & Co LLY
- Johnson & Johnson JNJ
- AbbVie Inc. ABBV
- Merck & Co., Inc. MRK
- Novartis AG NVS
- Astrazeneca PLC AZN
- Abbott Laboratories ABT
- Novo Nordisk A S NVO
Source: SEC EDGAR filings. This is company-reported data, not investment advice.